PGI2 inhibits ischemia-induced platelet activation and prevents myocardial damage by inhibition of catecholamine release from adrenergic nerve terminals. Evidence for cAMP as common denominator

Thromb Res. 1981 Jan;21(1-2):175-80. doi: 10.1016/0049-3848(84)90046-x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Fibers / metabolism
  • Animals
  • Arachidonic Acids / pharmacology
  • Blood Platelets / physiopathology*
  • Catecholamines / metabolism
  • Cats
  • Contractile Proteins / pharmacology
  • Coronary Disease / etiology*
  • Cyclic AMP / metabolism
  • Epoprostenol / pharmacology*
  • Female
  • Male
  • Myocardium / pathology*
  • Prostaglandins / pharmacology*
  • Rabbits

Substances

  • Arachidonic Acids
  • Catecholamines
  • Contractile Proteins
  • Prostaglandins
  • Epoprostenol
  • Cyclic AMP